HALLEY DONLIN: Open Payments
NPI 1548991540 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 14 payments from 9 companies in 2025. Trend: 2023 $131 · 2024 $130 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $72 |
| Novo Nordisk Inc | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Seqirus USA Inc | 1 | $24 |
| PFIZER INC. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: MOUNJARO, JARDIANCE, CAPVAXIVE, Rybelsus, Flucelvax, Wegovy, NURTEC ODT, Veozah.
Industry payments across DE — which companies pay providers there.
